On the occasion of Childhood Cancer Awareness Month, pediatric oncologist Paul A. Meyers talks about the evolution of pediatric cancer research and treatment at Memorial Sloan-Kettering.
In a large-scale genome-sequencing study, researchers have discovered mutations in neuroblastoma tumors that could aid the development of diagnostic tests and therapies.
